NAD Flags IQ BAR's 'Superior Brain and Body Nutrition' Claim

The National Advertising Division (NAD) has recommended that IQ BAR Inc. discontinue its "superior brain and body nutrition" claim, flagging the assertion as inadequately substantiated under self-regulatory advertising standards. The action emerged from the NAD's routine, ongoing monitoring program — not a competitor challenge — meaning the claim caught the attention of independent reviewers scanning the functional food and supplement space.

The NAD, administered by BBB National Programs, is the primary self-regulatory body for national advertising in the U.S. Its recommendations carry significant weight: brands that do not comply risk referral to the Federal Trade Commission. For functional food and bar brands making structure-function-adjacent superiority claims, the case is a signal that "best-in-class" positioning language requires documented, competent, and reliable scientific evidence — not just a compelling ingredient stack.

What the Claim Implies

The phrase "superior brain and body nutrition" is a comparative superiority claim, which under NAD guidelines demands head-to-head evidence demonstrating measurable advantage over competing products. That bar is materially higher than a standard structure-function claim, which must only link an ingredient to a normal body function. IQ BAR's products are built around ingredients commonly associated with cognitive and physical performance — including lion's mane, omega-3s, and B vitamins — but ingredient presence alone does not satisfy a comparative superiority standard.

This distinction matters broadly for the functional snack and bar category, where brands routinely layer nootropic, adaptogen, and performance ingredients and then reach for superlative marketing language. The NAD's monitoring program has become increasingly active in this space as better-for-you positioning proliferates across retail channels.

Operator and Brand Implications

For manufacturers and brand teams formulating in the cognitive-health and functional-nutrition segments, the IQ BAR case reinforces a practical compliance principle: superiority claims require superiority data. Finished formulation brands competing in the nootropic and brain-health market should audit any claim language that implies outperforming a category or class of products without published, peer-reviewed clinical support at the finished-product level.

The global brain-health supplement market has expanded rapidly, driven by consumer interest in cognitive performance, focus, and stress resilience. That growth has also attracted closer self-regulatory and regulatory scrutiny — from NAD monitoring to FTC enforcement actions targeting unsubstantiated health claims. Brands that substantiate efficacy with double-blind, placebo-controlled trial data, clearly tied to their finished formulation and actual serving dose, are best positioned to defend premium positioning language over the long term.

IQ BAR has not publicly indicated whether it will appeal the NAD's recommendation or modify its marketing.

Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.